[1]张燕飞,张 博,陈苏宁.苓桂术甘汤加味联合卡托普利对慢性心力衰竭大鼠BNP、ET-1、Caspase-3水平影响的研究[J].陕西中医,2021,(6):701-704.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.005]
 ZHANG Yanfei,ZHANG Bo,CHEN Suning.Study on the influence of modified Linggui Zhugan prescription combined with captopril on BNP,ET-1 and Caspase-3 levels in chronic heart failure rats[J].,2021,(6):701-704.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.005]
点击复制

苓桂术甘汤加味联合卡托普利对慢性心力衰竭大鼠BNP、ET-1、Caspase-3水平影响的研究
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年6期
页码:
701-704
栏目:
基础研究
出版日期:
2021-06-05

文章信息/Info

Title:
Study on the influence of modified Linggui Zhugan prescription combined with captopril on BNP,ET-1 and Caspase-3 levels in chronic heart failure rats
作者:
张燕飞张 博陈苏宁
(中国医科大学附属盛京医院,辽宁 沈阳 110004)
Author(s):
ZHANG YanfeiZHANG BoCHEN Suning
(Shengjing Hospital of China Medical University,Shenyang 110004,China)
关键词:
慢性心力衰竭 B型尿钠肽 内皮素-1 半胱氨酸天冬氨酸蛋白酶3 苓桂术甘汤加味 大鼠
Keywords:
Chronic heart failure B-type natriuretic peptide Endothelin-1 Cysteine aspartate specific protease 3 Modified Linggui Zhugan prescription Rats
分类号:
R 541.6
DOI:
DOI:10.3969/j.issn.1000-7369.2020.06.005
文献标志码:
A
摘要:
目的:探讨苓桂术甘汤加味联合卡托普利对心力衰竭大鼠血清B型钠尿肽(BNP)、内皮素-1(ET-1)、半胱氨酸天冬氨酸蛋白酶3(Caspase-3)水平的影响。方法:选取40只SPF级SD大鼠,连续1周腹腔注射异丙肾上腺素,建立慢性心力衰竭大鼠模型,左室射血分数(LVEF)≤60%则造模成功。将造模成功的SD大鼠随机分为心衰组、中药组、西药组、联合组进行观察。结果:光镜下观察各组大鼠心肌病理形态学变化,与心衰组比较,给予药物治疗的三组心肌病理学形态有所改善,血清BNP、ET-1、Caspase-3水平降低,LVEF升高,心脏质量指数下降。结论:苓桂术甘汤加味联合卡托普利能减轻慢性心力衰竭大鼠心肌细胞的病理损伤,降低血清BNP、ET-1、Caspase-3水平及心脏质量指数,提高LVEF水平,改善心功能。
Abstract:
Objective:To investigate the effects of modified Linggui Zhugan prescription combined with captopril on serum levels of BNP,ET-1 and Caspase-3 in rats with chronic heart failure.Methods:40 SPF SD rats were selected and intraperitoneally injected with isoproterenol for one week to establish the rat model of chronic heart failure.LVEF≤60% the model was successfully established.SD rats were randomly divided into heart failure group,Chinese medicine group,western medicine group,combined group for observation.Results:The pathological morphological changes of myocardium were observed under light microscope.Compared with the heart failure group,the pathological morphological changes of myocardium in the three groups treated with drugs were improved with decreased serum levels of BNP,ET-1 and Caspase-3,increased LVEF and decreased heart mass index.Conclusion:Modified Linggui Zhugan prescription combined with captopril can reduce the pathological damage of cardiomyocytes in rats with chronic heart failure,reduce serum BNP,ET-1,Caspase-3 levels and heart mass index,increase LVEF level,decrease,and improve cardiac function.

参考文献/References:

[1] 彭玉霞,卢桂林,张斌霞.中医药治疗慢性心力衰竭的研究进展[J].中国中医急症,2020,29(2):373-376.
[2] 李 刚,陈紫凡.左西孟旦治疗老年慢性心力衰竭患者临床疗效及对患者心功能、肾素-血管紧张素-醛固酮系统的影响[J].陕西医学杂志,2020,49(10):1321-1324.
[3] 姜国臣,徐曼曼,张久亮.从心包藏论治心衰病的初步探讨[J].环球中医药,2019,12(8):1254-1255.
[4] 郭庆凯,王忠良.BNP、血清胱抑素C和血清前白蛋白对重症心衰的临床诊断价值分析[J].世界最新医学信息文摘,2019,19(93):210-211.
[5] Atas E,Kismet E,Kesik V,et al.Cardiac troponin-1,brain natriuretic peptide and endothelin-1 levels in a rat model of doxorubicin-induced cardiac injury[J].Cancer Res Ther,2015,11(4):882-886.
[6] Kumar K,Afonso L.Cardiovascular risk prediction in the elderly[J].Geriatr Cardiol,2019,16(5):414-420.
[7] Savoj J,Becerra B,Kim JK,et al.Utility of cardiac biomarkers in the setting of kidney disease[J].Nephron,2019,141(4):227-235.
[8] Tang J,Xie Q,Ma D,et al.Effects of ET-1 and TNF-α levels on the cardiac function and prognosis in rats with chronic heart failure[J].Eur Rev Med Pharmacol Sci,2019,23(24):11004-11010.
[9] Jankowich M,Choudhary G.Endothelin-1 levels and cardiovascular events[J].Trends Cardiovasc Med,2020,30(1):1-8.
[10] Qin L,Liu X,Li Y.Correlation of serum BNP and ET-1 levels with cardiac pump function and ventricular remodeling in patients with heart failure[J].Cell Mol Biol,2020,66(3):125-131.
[11] Mahmoudabady M,Niazmand S,Shafei MN,et al.Investigation of apoptosis in a canine model of chronic heart failure induced by tachycardia[J].Acta Physiol Hung,2013,100(4):435-444.
[12] Wang QW,Yu XF,Xu HL,et al.Ginsenoside improves isoproterenol-induced myocardial fibrosis and heart failure in rats[J].Evid Based Complement Alternat Med,2019,13(1):371-378.
[13] 金 政,吴 伟,皮建彬,等.国医大师邓铁涛辨治心力衰竭的经验[J].中国中西医结合杂志,2020,40(6):754-755.
[14] 张 艳,杨 继,冯 伟.中医药治疗慢性心力衰竭研究进展[J].现代中西医结合杂志,2019,28(32):3638-3641.
[15] 颉志英,张志明,雍文兴,等.益气活血法调控心肌缺血再灌注损伤细胞自噬研究进展[J].中国中医药信息杂志,2020,27(12):130-134.
[16] 刘蓉芳,郑洪波,黄火剑,等.慢性心力衰竭心肾阳虚证、心阳虚证大鼠vWF、ET-1表达差异研究[J].江西中医药,2019,50(10):37-40.
[17] Soufer R,Fernande ZB,Meadows J,et al.Body mass index and risk for mental stress induced ischemia in coronary artery disease[J].Mol Med,2016,39(22):286-291.
[18] Bossard M,Pumpol K,Vander LS,et al.Plasma endothelin-1 and cardiovascular risk among young and healthy adults[J].Atherosclerosis,2015,239(1):186-191.
[19] Horckmans M,Esfahani H,Beauloye C,et al.Loss of mouse P2Y4 nucleotide receptor protects against myocardial infarction through endothelin-1 downregulation[J].Journal Immunol,2015,194(4):1874-1881.
[20] Wang L,Song L,Li C,et al.Renal denervation improves cardiac function by attenuating myocardiocyte apoptosis in dogs after myocardial infarction[J].Bmc Cardiovasc Disord,2018,18(1):86-90.

相似文献/References:

[1]杨自生,金 琪,简立国.参苓养心汤治疗慢性心衰的疗效及对心功能、活动耐力、 NTProBNP、hsCRP的影响*[J].陕西中医,2019,(2):167.
 YANG Zisheng,JIN Qi,JIAN Liguo..The effect of Shenling Yangxin decoction on chronic heart failure and its effect on cardiac function,activity endurance,NTProBNP and hsCRP[J].,2019,(6):167.
[2]孙 哲,杨 默,石宗华.丹参多酚酸盐与丹参酮治疗慢性心力衰竭临床研究[J].陕西中医,2019,(5):591.
 SUN Zhe,YANG Mo,SHI Zonghua..Clinical effect and mechanism of salvianolate and Tanshinone in the treatment of chronic heart failure[J].,2019,(6):591.
[3]向宗兴,拓 文,仇卫峰,等.黄芪保心汤配合西药治疗慢性心力衰竭临床研究*[J].陕西中医,2019,(8):1085.
 XIANG Zongxing,TUO Wen,QIU Weifeng,et al.Clinical value of Huangqi Baoxin decoction combined with western medicine in the treatment of chronic heart failure[J].,2019,(6):1085.
[4]尚加芬.参芪附仙饮联合盐酸曲美他嗪片辨治慢性心力衰竭心肾阳虚证临床研究[J].陕西中医,2020,(1):38.
[5]陈宗伟,沈志涛,郑振国,等.芪苈强心胶囊配合保元汤加减治疗慢性心力衰竭临床研究*[J].陕西中医,2020,(2):191.
 CHEN Zongwei,SHEN Zhitao,ZHENG Zhenguo,et al.Observation on the effect of Qili Qiangxin capsules assist Baoyuan decoction in the treatment of chronic heart failure[J].,2020,(6):191.
[6]凌 望,孙思明,王璐玲,等.温阳益气活血方改善慢性心力衰竭患者生活质量临床研究*[J].陕西中医,2020,(5):621.[doi:DOI:10.3969/j.issn.10007369.2020.05.019]
 LING Wang,SUN Siming,WANG Luling,et al.A Study on the quality of life about Wenyang Yiqi Huoxue therapy in the treatment of chronic heart failure[J].,2020,(6):621.[doi:DOI:10.3969/j.issn.10007369.2020.05.019]
[7]朱 杰,林兆奋△,胡 聃,等.中西医结合治疗慢性心力衰竭研究进展*[J].陕西中医,2020,(9):1342.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.046]
[8]李幼萍,肖忠英,倪 卫.黄芪保心汤联合比索洛尔治疗射血分数保留型心力衰竭疗效及对患者心功能的影响*[J].陕西中医,2020,(10):1399.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.016]
 LI Youping,XIAO Zhongying,NI Wei..Clinical efficacy of Huangqi Baoxin decoction combined with bisoprolol in the treatment of heart failure with preserved ejection fraction and its effects on cardiac function and 6MWT[J].,2020,(6):1399.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.016]
[9]刘 薇,张玉焕,李 争.芪参益气滴丸对老年气虚血瘀型心力衰竭患者心肌保护、炎症状态的影响[J].陕西中医,2021,(1):37.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.008]
 LIU Wei,ZHANG Yuhuan,LI Zheng.Effects of Qishen Yiqi dropping pills on myocardial protection,inflammatory state and serum cell adhesion molecule level in elderly patients with heart failure caused by qi deficiency and blood stasis[J].,2021,(6):37.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.008]
[10]黄光明.理中汤加减治疗慢性心力衰竭及对患者血清BNP、IL-10及NOS水平的影响研究[J].陕西中医,2021,(2):159.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.006]
 HUANG Guangming.Modified Lizhong decoction on clinical symptoms and levels of serum BNP,IL-10 and NOS in patients with chronic heart failure[J].,2021,(6):159.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.006]

备注/Memo

备注/Memo:
基金项目:辽宁省自然科学基金资助项目(MB87)
更新日期/Last Update: 2021-06-09